Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests
- PMID: 23302110
- PMCID: PMC3672666
- DOI: 10.1186/ar4136
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests
Abstract
Introduction: Microcirculation dysfunction is a typical feature of systemic sclerosis (SSc) and represents the earliest abnormality of primary myocardial involvement. We assessed coronary microcirculation status by combining two functional tests in SSc patients and estimating its impact on disease outcome.
Methods: Forty-one SSc patients, asymptomatic for coronary artery disease, were tested for coronary flow velocity reserve (CFR) by transthoracic-echo-Doppler with adenosine infusion (A-TTE) and for left ventricular wall motion abnormalities (WMA) by dobutamine stress echocardiography (DSE). Myocardial multi-detector computed tomography (MDCT) enabled the presence of epicardial stenosis, which could interfere with the accuracy of the tests, to be excluded. Patient survival rate was assessed over a 6.7-±3.5-year follow-up.
Results: Nineteen out of 41 (46%) SSc patients had a reduced CFR (≤2.5) and in 16/41 (39%) a WMA was observed during DSE. Furthermore, 13/41 (32%) patients showed pathological CFR and WMA. An inverse correlation between wall motion score index (WMSI) during DSE and CFR value (r=-0.57, P<0.0001) was observed; in addition, CFR was significantly reduced (2.21±0.38) in patients with WMA as compared to those without (2.94±0.60) (P<0.0001). In 12 patients with abnormal DSE, MDCT was used to exclude macrovasculopathy. During a 6.7-±3.5-year follow-up seven patients with abnormal coronary functional tests died of disease-related causes, compared to only one patient with normal tests.
Conclusions: A-TTE and DSE tests are useful tools to detect non-invasively pre-clinical microcirculation abnormalities in SSc patients; moreover, abnormal CFR and WMA might be related to a worse disease outcome suggesting a prognostic value of these tests, similar to other myocardial diseases.
Figures



Similar articles
-
Evaluation of left anterior descending coronary artery stenosis of intermediate severity using transthoracic coronary flow reserve and dobutamine stress echocardiography.J Am Soc Echocardiogr. 2005 Dec;18(12):1233-40. doi: 10.1016/j.echo.2005.05.011. J Am Soc Echocardiogr. 2005. PMID: 16376748 Clinical Trial.
-
Blunted coronary flow reserve in systemic sclerosis.Rheumatology (Oxford). 2004 Apr;43(4):505-9. doi: 10.1093/rheumatology/keh087. Epub 2004 Jan 20. Rheumatology (Oxford). 2004. PMID: 14734787
-
Correlation between left ventricular global and regional longitudinal systolic strain and impaired microcirculation in patients with acute myocardial infarction.Echocardiography. 2012 Nov;29(10):1181-90. doi: 10.1111/j.1540-8175.2012.01784.x. Epub 2012 Aug 3. Echocardiography. 2012. PMID: 22862151
-
Transthoracic coronary flow reserve and dobutamine derived myocardial function: a 6-month evaluation after successful coronary angioplasty.Cardiovasc Ultrasound. 2004 Dec 6;2:26. doi: 10.1186/1476-7120-2-26. Cardiovasc Ultrasound. 2004. PMID: 15581428 Free PMC article. Clinical Trial.
-
Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography.Clin Physiol Funct Imaging. 2008 May;28(3):145-55. doi: 10.1111/j.1475-097X.2008.00794.x. Epub 2008 Feb 26. Clin Physiol Funct Imaging. 2008. PMID: 18312446 Review.
Cited by
-
Coronary Flow Velocity Reserve by Echocardiography: Beyond Atherosclerotic Disease.Diagnostics (Basel). 2023 Jan 5;13(2):193. doi: 10.3390/diagnostics13020193. Diagnostics (Basel). 2023. PMID: 36673004 Free PMC article. Review.
-
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.Eur Heart J. 2022 Apr 19;43(16):1582-1593. doi: 10.1093/eurheartj/ehab775. Eur Heart J. 2022. PMID: 34849697 Free PMC article.
-
The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions.Commun Biol. 2023 Feb 9;6(1):161. doi: 10.1038/s42003-023-04534-6. Commun Biol. 2023. PMID: 36759717 Free PMC article.
-
Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain.Front Cardiovasc Med. 2022 Apr 15;9:867155. doi: 10.3389/fcvm.2022.867155. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35498009 Free PMC article. Review.
-
Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.Front Med (Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29497612 Free PMC article. Review.
References
-
- Black C, Myers A. Proceedings of the International Conference on Progressive Systemic Sclerosis. Austin, TX, USA, Oct; 1981. Current topics in rheumatology: Systemic Sclerosis (Scleroderma) pp. 20–23.
-
- Roberts NK, Cabeen WR, Moss J, Clements PJ, Furst DE. The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med. 1981;94:38–40. - PubMed
-
- Follansbee WP. The cardiovascular manifestation of systemic sclerosis (scleroderma) Curr Probl Cardiol. 1986;11:241–298. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical